Home LiteratureArticle Details
PMID: 17113097 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Method for generation of in vivo biotinylated recombinant antibodies by yeast mating.

Journal of immunological methods ·Vol. 317 ·No. 1-2 ·2006-12-20 ·Pages 132-43

Scholler N, Garvik B, Quarles T, Jiang S, Urban N

Abstract

We describe here a novel method for generation of yeast-secreted, in vivo biotinylated recombinant antibodies, or biobodies. Biobodies are secreted by diploid yeast resulting from the fusion of two haploid yeast of opposite mating type. One yeast carries a cDNA encoding an antibody recognition sequence fused to an IgA1 hinge and a biotin acceptor site (BCCP) at the C-terminus; the other carries a cDNA encoding an E. coli biotin ligase (BirA) fused to KEX2 golgi-localization sequences, so that BirA can catalyze the biotin transfer to the recognition sequence-fused BCCP within the yeast secretory compartment. We illustrate this technology with biobodies against HE4, a biomarker for ovarian carcinoma. Anti-HE4 biobodies were derived from clones or pools of anti-HE4-specific yeast-display scFv, constituting respectively monoclonal (mBb) or polyclonal (pBb) biobodies. Anti-HE4 biobodies were secreted directly biotinylated thus bound to labeled-streptavidin and streptavidin-coated surfaces without Ni-purification. Anti-HE4 biobodies demonstrated specificity and sensitivity by ELISA assays, flow cytometry analysis and Western blots prior to any maturation; dissociation equilibrium constants as measured by surface plasmon resonance sensor were of K(d)=4.8 x 10(-9) M and K(d)=5.1 x 10(-9) M before and after Ni-purification respectively. Thus, yeast mating permits cost-effective generation of biotinylated recombinant antibodies of high affinity.

MeSH Terms
Antibodies/immunology Antibody Affinity Biotinylation Blotting, Western Cell Line Epididymal Secretory Proteins/immunology Flow Cytometry Humans Recombinant Fusion Proteins/biosynthesis,immunology Surface Plasmon Resonance Transfection Yeasts beta-Defensins
Chemicals
Antibodies DEFB126 protein, human Epididymal Secretory Proteins Recombinant Fusion Proteins beta-Defensins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Scholler Nathalie
Translational Outcomes Research Group, Molecular Diagnostics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA. nscholle@fhcrc.org
Garvik Barbara
Quarles Travis
Jiang Shaoyi
Urban Nicole
References (55)
55 references, click to expand
  1. A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease.
    Proteomics. 2003 Aug;3(8):1486-94 PMID: 12923774
  2. Protein detection using proximity-dependent DNA ligation assays.
    Nat Biotechnol. 2002 May;20(5):473-7 PMID: 11981560
  3. Splice variants as cancer biomarkers.
    Clin Biochem. 2004 Jul;37(7):584-94 PMID: 15234240
  4. DNA-directed protein immobilization on mixed self-assembled monolayers via a streptavidin bridge.
    Langmuir. 2004 Sep 14;20(19):8090-5 PMID: 15350077
  5. Optical rotatory dispersion, circular dichroism and far-ultraviolet spectra of avidin and streptavidin.
    Biochem J. 1966 Sep;100(3):614-21 PMID: 5969276
  6. The birA gene of Escherichia coli encodes a biotin holoenzyme synthetase.
    J Mol Biol. 1981 Mar 15;146(4):451-67 PMID: 7024555
  7. Genetic and biochemical characterization of the birA gene and its product: evidence for a direct role of biotin holoenzyme synthetase in repression of the biotin operon in Escherichia coli.
    J Mol Biol. 1981 Mar 15;146(4):469-92 PMID: 6456358
  8. Nucleotide sequence of the birA gene encoding the biotin operon repressor and biotin holoenzyme synthetase functions of Escherichia coli.
    Gene. 1985;35(3):321-31 PMID: 3899863
  9. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli.
    Gene. 1987;57(2-3):267-72 PMID: 3319781
  10. Evolutionary conservation among biotin enzymes.
    J Biol Chem. 1988 May 15;263(14):6461-4 PMID: 2896195
  11. Intracellular targeting and structural conservation of a prohormone-processing endoprotease.
    Science. 1989 Oct 27;246(4929):482-6 PMID: 2683070
  12. Biotination of proteins in vivo. A post-translational modification to label, purify, and study proteins.
    J Biol Chem. 1990 Jun 25;265(18):10327-33 PMID: 2113052
  13. Protein biotinylation.
    Methods Enzymol. 1990;184:138-60 PMID: 2388567
  14. A rapid method for localized mutagenesis of yeast genes.
    Yeast. 1992 Feb;8(2):79-82 PMID: 1561838
  15. Mutation of a tyrosine localization signal in the cytosolic tail of yeast Kex2 protease disrupts Golgi retention and results in default transport to the vacuole.
    Mol Biol Cell. 1992 Dec;3(12):1353-71 PMID: 1493334
  16. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli.
    Biotechnology (N Y). 1993 Oct;11(10):1138-43 PMID: 7764094
  17. Regulatable promoters of Saccharomyces cerevisiae: comparison of transcriptional activity and their use for heterologous expression.
    Nucleic Acids Res. 1994 Dec 25;22(25):5767-8 PMID: 7838736
  18. Vectors for expression and secretion of FLAG epitope-tagged proteins in mammalian cells.
    Biotechniques. 1996 Jan;20(1):136-41 PMID: 8770418
  19. Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment-core streptavidin fusion.
    Protein Eng. 1996 Feb;9(2):203-11 PMID: 9005442
  20. A plasmid expression system for quantitative in vivo biotinylation of thioredoxin fusion proteins in Escherichia coli.
    Nucleic Acids Res. 1998 Mar 15;26(6):1414-20 PMID: 9490786
  21. CLAMP: a biosensor kinetic data analysis program.
    Trends Biochem Sci. 1998 Apr;23(4):149-50 PMID: 9584619
  22. In vitro enzymatic biotinylation of recombinant fab fragments through a peptide acceptor tail.
    Bioconjug Chem. 1998 Nov-Dec;9(6):725-35 PMID: 9815166
  23. Protein arrays for studying blood cells and their secreted products.
    Immunol Rev. 2005 Apr;204:264-82 PMID: 15790364
  24. Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer.
    Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):981-7 PMID: 15824174
  25. Use of an in vivo biotinylated single-chain antibody as capture reagent in an immunometric assay to decrease the incidence of interference from heterophilic antibodies.
    Clin Chem. 2005 May;51(5):830-8 PMID: 15718486
  26. Using protein-DNA chimeras to detect and count small numbers of molecules.
    Nat Methods. 2005 Jan;2(1):31-7 PMID: 15782158
  27. Molecular signature analysis: using the myocardial transcriptome as a biomarker in cardiovascular disease.
    Trends Cardiovasc Med. 2005 May;15(4):130-8 PMID: 16099376
  28. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database.
    Proteomics. 2005 Aug;5(13):3226-45 PMID: 16104056
  29. A functional annotation of subproteomes in human plasma.
    Proteomics. 2005 Aug;5(13):3506-19 PMID: 16104058
  30. Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis.
    BMC Cancer. 2005;5:110 PMID: 16117833
  31. Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray.
    PLoS Med. 2005 Oct;2(10):e265 PMID: 16162034
  32. Directed evolution for the development of conformation-specific affinity reagents using yeast display.
    Protein Eng Des Sel. 2005 Nov;18(11):527-36 PMID: 16186140
  33. Chromatin modifier enzymes, the histone code and cancer.
    Eur J Cancer. 2005 Nov;41(16):2381-402 PMID: 16226460
  34. Biomarkers for diagnosing and monitoring autoimmune diseases.
    Biomarkers. 2005 Nov;10 Suppl 1:S44-9 PMID: 16298911
  35. DNA-directed protein immobilization for simultaneous detection of multiple analytes by surface plasmon resonance biosensor.
    Anal Chem. 2006 Mar 1;78(5):1515-9 PMID: 16503602
  36. Bead-based ELISA for validation of ovarian cancer early detection markers.
    Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2117-24 PMID: 16609024
  37. Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery.
    Cancer Lett. 2007 Mar 8;247(1):130-6 PMID: 16677756
  38. Adaptive evolution of the IgA hinge region in primates.
    Mol Biol Evol. 2002 Jul;19(7):1093-9 PMID: 12082128
  39. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor.
    Science. 2002 Nov 1;298(5595):995-1000 PMID: 12351674
  40. Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library.
    Nat Biotechnol. 2003 Feb;21(2):163-70 PMID: 12536217
  41. The case for early detection.
    Nat Rev Cancer. 2003 Apr;3(4):243-52 PMID: 12671663
  42. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.
    Cancer Res. 2003 Jul 1;63(13):3695-700 PMID: 12839961
  43. A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation.
    Protein Sci. 1999 Apr;8(4):921-9 PMID: 10211839
  44. In vivo biotinylated recombinant antibodies: high efficiency of labelling and application to the cloning of active anti-human IgG1 Fab fragments.
    J Immunol Methods. 1999 Apr 22;224(1-2):129-40 PMID: 10357213
  45. Aberrant and alternative splicing in cancer.
    Cancer Res. 2004 Nov 1;64(21):7647-54 PMID: 15520162
  46. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
    J Immunol Methods. 2004 Nov;294(1-2):23-35 PMID: 15604013
  47. Proteomic analyzes of copper metabolism in an in vitro model of Wilson disease using surface enhanced laser desorption/ionization-time of flight-mass spectrometry.
    J Cell Biochem. 2004 Nov 1;93(4):732-40 PMID: 15660417
  48. Alterations of pre-mRNA splicing in cancer.
    Genes Chromosomes Cancer. 2005 Apr;42(4):342-57 PMID: 15648050
  49. SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma.
    Hepatology. 2005 Mar;41(3):634-42 PMID: 15726646
  50. Spectral surface plasmon resonance biosensor for detection of staphylococcal enterotoxin B in milk.
    Int J Food Microbiol. 2002 May 5;75(1-2):61-9 PMID: 11999118
  51. Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas.
    Gene. 1999 Oct 1;238(2):375-85 PMID: 10570965
  52. Multiplexed particle-based flow cytometric assays.
    J Immunol Methods. 2000 Sep 21;243(1-2):243-55 PMID: 10986418
  53. Histone acetylation modifiers in the pathogenesis of malignant disease.
    Mol Med. 2000 Aug;6(8):623-44 PMID: 11055583
  54. Streptabody, a high avidity molecule made by tetramerization of in vivo biotinylated, phage display-selected scFv fragments on streptavidin.
    Mol Immunol. 2000 Dec;37(17):1067-77 PMID: 11399324
  55. Production of a biotinylated single-chain antibody fragment in the cytoplasm of Escherichia coli.
    J Immunol Methods. 2004 Jan;284(1-2):165-75 PMID: 14736427
Article Info
Journal
Journal of immunological methods
Abbr.
J Immunol Methods
ISSN
0022-1759
Published
2006-12-20
Epub
2006-00-30
Pages
132-43
Language
English
Region
Netherlands
NLM ID
1305440
PMCID
PMC1784068
Subset
IM
Grants
NCI NIH HHS · P50 CA083636 · United States
NCI NIH HHS · P50 CA83636 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com